Importantly, changes in the effective nuclear levels of REST are pathological in cancer [13], [14], as well as cardiac hypertrophy [15], vascular smooth muscle proliferation [12], ischaemia [16] and Huntington's disease [17]. This evidence concerns the gene REST and hypertrophy.